SpecGx, LLC recalls Oxycodone and Acetaminophen CII Tablets USP
- Published
- 14 Jan 2026
- Units affected
- 2 products
- Agency
- FDA
- Country
- United States
The hazard
Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Oxycodone and Acetaminophen CII Tablets USP, 10mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119, NDC 0406-0523-01.
Oxycodone and Acetaminophen CII Tablets USP, 7.5 mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119, NDC 0406-0522-01. Case label: SpecGx LLC, NDC 0406052201, Exp. 2027/03, Lot: 0522J23493
- Brand / company
- SpecGx, LLC
- Codes / lots
- Lot: 0523J23904, expires: 05/2027; 0523J24426, 0523J24427, expires: 06/2027. | Lot: 0522J23493, expires: 03/2027.
- Distribution
- Nationwide
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 14 Jan 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.